Susan Tsai

8PUBLICATIONS
47CO-AUTHORS
Molecular targetsPredictive and prognostic markersEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 30, 2026
Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer.

|Aug 27, 2026
Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer.

|Oct 24, 2025
Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma.

Mandana Kamgar, G Aaron Hobbes, Raven Davidson

|Dec 23, 2023
Characterization of an oligometastatic state in patients with metastatic pancreatic adenocarcinoma undergoing systemic chemotherapy.

Saryleine de Ortiz de Choudens, Alexis Visotcky, Anjishnu Banerjee

|Mar 24, 2023
Neoadjuvant chemotherapy for pancreatic cancer: Quality over quantity.

Sam Z Thalji, Mohammed Aldakkak, Kathleen K Christians

|Dec 08, 2022
Outcomes of plastic surgical reconstruction in extremity and truncal soft tissue sarcoma: Results from the US Sarcoma Collaborative.

Sam Z Thalji, Cecilia G Ethun, Susan Tsai

Pageof 2

Frequent Collaborators

4 joint publications

Mandana Kamgar

3 joint publications

Sam Z Thalji

3 joint publications

John F Langenheim

3 joint publications

Juliannie Herrera